Neuroinflammacil

Aurum Muriaticum, Hyoscyaminum, Cerebrum Suis, Hedera Helix, Hura Brasiliensis, Cedron, Hypericum Perforatum


Nucleic Products, Llc
Human Otc Drug
NDC 75053-0001
Neuroinflammacil also known as Aurum Muriaticum, Hyoscyaminum, Cerebrum Suis, Hedera Helix, Hura Brasiliensis, Cedron, Hypericum Perforatum is a human otc drug labeled by 'Nucleic Products, Llc'. National Drug Code (NDC) number for Neuroinflammacil is 75053-0001. This drug is available in dosage form of Liquid. The names of the active, medicinal ingredients in Neuroinflammacil drug includes Gold Trichloride - 12 [hp_X]/mL Hedera Helix Flowering Twig - 30 [hp_C]/mL Hura Crepitans Sap - 30 [hp_C]/mL Hyoscyamine - 16 [hp_X]/mL Hypericum Perforatum Whole - 200 [hp_C]/mL Simaba Cedron Seed - 200 [hp_C]/mL Sus Scrofa Cerebrum - 3 [hp_C]/mL . The currest status of Neuroinflammacil drug is Active.

Drug Information:

Drug NDC: 75053-0001
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Neuroinflammacil
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Aurum Muriaticum, Hyoscyaminum, Cerebrum Suis, Hedera Helix, Hura Brasiliensis, Cedron, Hypericum Perforatum
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Nucleic Products, Llc
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Liquid
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:GOLD TRICHLORIDE - 12 [hp_X]/mL
HEDERA HELIX FLOWERING TWIG - 30 [hp_C]/mL
HURA CREPITANS SAP - 30 [hp_C]/mL
HYOSCYAMINE - 16 [hp_X]/mL
HYPERICUM PERFORATUM WHOLE - 200 [hp_C]/mL
SIMABA CEDRON SEED - 200 [hp_C]/mL
SUS SCROFA CEREBRUM - 3 [hp_C]/mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 29 Jun, 2020
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 06 May, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Nucleic Products, LLC
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:15443PR153
3D10KUA6BM
8UHN1I06UP
PX44XO846X
XK4IUX8MNB
KHI40967MV
4GB5DQR532
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
75053-0001-1118 mL in 1 BOTTLE, DROPPER (75053-0001-1)29 Jun, 2020N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Indications: for the temporary relief of inflammation, headache, irritability, poor concentration, diminished memory, fatigue, or general weakness. claims based on homeopathic theory, not accepted medical evidence. not fda evaluated.

Product Elements:

Neuroinflammacil aurum muriaticum, hyoscyaminum, cerebrum suis, hedera helix, hura brasiliensis, cedron, hypericum perforatum gold trichloride gold cation (3+) hyoscyamine hyoscyamine sus scrofa cerebrum sus scrofa cerebrum hedera helix flowering twig hedera helix flowering twig hura crepitans sap hura crepitans sap simaba cedron seed simaba cedron seed hypericum perforatum whole hypericum perforatum water alcohol

Indications and Usage:

Indications: for the temporary relief of inflammation, headache, irritability, poor concentration, diminished memory, fatigue, or general weakness. claims based on homeopathic theory, not accepted medical evidence. not fda evaluated.

Warnings:

Warnings: if pregnant or breast-feeding, ask a health professional before use. keep out of reach of children. in case of overdose, get medical help or contact a poison control center right away. do not use if seal is broken or missing. this product does not contain sugar, starch, salt, preservatives, artificial flavors or additives, and no wheat, gluten, soy or milk derivatives.

Dosage and Administration:

Directions: place drops under tongue 30 minutes before/after meals. adults and children 12 years and over: take one full dropper up to 2 times a day. consult a physician for use in children under 12 years of age.

Package Label Principal Display Panel:

Package label display: ndc: 75053-0001-1 nu cleic neuroinflammacil homeopathic medicine for professional use only 4 fl oz. (118 ml) neuroinflammacil

Further Questions:

Questions: distributed by: nucleic products, llc po box 7148 grove, ok 74344


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.